These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 37685930)

  • 1. Patterns of IgA Autoantibody Generation, Inflammatory Responses and Extracellular Matrix Metabolism in Patients with Alcohol Use Disorder.
    Niemelä O; Bloigu A; Bloigu R; Nivukoski U; Kultti J; Pohjasniemi H
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An inverse relationship between markers of fibrogenesis and collagen degradation in patients with or without alcoholic liver disease.
    Koivisto H; Hietala J; Niemelä O
    Am J Gastroenterol; 2007 Apr; 102(4):773-9. PubMed ID: 17222322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-occurrence of IgA antibodies against ethanol metabolites and tissue transglutaminase in alcohol consumers: correlation with proinflammatory cytokines and markers of fibrogenesis.
    Koivisto H; Hietala J; Anttila P; Niemelä O
    Dig Dis Sci; 2008 Feb; 53(2):500-5. PubMed ID: 17597408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune Responses to Ethanol Metabolites and Cytokine Profiles Differentiate Alcoholics with or without Liver Disease.
    Latvala J; Hietala J; Koivisto H; Järvi K; Anttila P; Niemelä O
    Am J Gastroenterol; 2005 Jun; 100(6):1303-10. PubMed ID: 15929761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgA immune responses against acetaldehyde adducts and biomarkers of alcohol consumption in patients with IgA glomerulonephritis.
    Kaartinen K; Niemelä O; Syrjänen J; Alatalo P; Pörsti I; Harmoinen A; Pasternack A; Huhtala H; Mustonen J
    Alcohol Clin Exp Res; 2009 Jul; 33(7):1231-7. PubMed ID: 19389190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum IgA, IgG, and IgM antibodies directed against acetaldehyde-derived epitopes: relationship to liver disease severity and alcohol consumption.
    Viitala K; Israel Y; Blake JE; Niemelä O
    Hepatology; 1997 Jun; 25(6):1418-24. PubMed ID: 9185762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum IgA levels and IgA/IgG ratio in Alcoholic Liver Disease.
    BhatB NM
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgAs against acetaldehyde-modified red cell protein as a marker of ethanol consumption in male alcoholic subjects, moderate drinkers, and abstainers.
    Hietala J; Koivisto H; Latvala J; Anttila P; Niemelä O
    Alcohol Clin Exp Res; 2006 Oct; 30(10):1693-8. PubMed ID: 17010136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood Cell Responses Following Heavy Alcohol Consumption Coincide with Changes in Acute Phase Reactants of Inflammation, Indices of Hemolysis and Immune Responses to Ethanol Metabolites.
    Niemelä O; Halkola AS; Bloigu A; Bloigu R; Nivukoski U; Pohjasniemi H; Kultti J
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbohydrate-deficient transferrin as a marker of alcohol abuse: relationship to alcohol consumption, severity of liver disease, and fibrogenesis.
    Niemelä O; Sorvajärvi K; Blake JE; Israel Y
    Alcohol Clin Exp Res; 1995 Oct; 19(5):1203-8. PubMed ID: 8561291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of serum calprotectin, a marker of neutrophil activation, and other mediators of inflammation in response to alcohol consumption.
    Nivukoski U; Bloigu A; Bloigu R; Kultti J; Tuomi H; Niemelä O
    Alcohol; 2021 Sep; 95():45-50. PubMed ID: 34228990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune responses against oxidant stress and acetaldehyde-derived epitopes in human alcohol consumers.
    Viitala K; Makkonen K; Israel Y; Lehtimäki T; Jaakkola O; Koivula T; Blake JE; Niemelä O
    Alcohol Clin Exp Res; 2000 Jul; 24(7):1103-9. PubMed ID: 10924016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers of alcohol consumption in patients classified according to the degree of liver disease severity.
    Anttila P; Järvi K; Latvala J; Romppanen J; Punnonen K; Niemelä O
    Scand J Clin Lab Invest; 2005; 65(2):141-51. PubMed ID: 16025837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum positivity of serum anti-tissue transglutaminase immunoglobulin A antibodies in Japanese children with inflammatory bowel disease.
    Kurasawa S; Sado T; Kato S; Iwaya M; Nakayama Y
    Pediatr Int; 2023 Jan; 65(1):e15485. PubMed ID: 36702637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgA antibodies against deamidated gliadin peptides in patients with chronic liver diseases.
    Gatselis NK; Zachou K; Norman GL; Tzellas G; Speletas M; Gabeta S; Germenis A; Koukoulis GK; Dalekos GN
    Clin Chim Acta; 2012 Oct; 413(19-20):1683-8. PubMed ID: 22643316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of carbohydrate-deficient transferrin, immunoglobulin A antibodies reactive with acetaldehyde-modified protein and acetaldehyde-modified albumin with conventional markers of alcohol consumption.
    Worrall S; de Jersey J; Wilce PA; Seppä K; Hurme L; Sillanaukee P
    Alcohol Clin Exp Res; 1998 Dec; 22(9):1921-6. PubMed ID: 9884134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity of carbohydrate-deficient transferrin (%CDT), gamma-glutamyltransferase (gamma-GT) and mean corpuscular erythrocyte volume (MCV) as biomarkers for chronic alcohol abuse: a study in patients with alcohol dependence and liver disorders of non-alcoholic and alcoholic origin.
    Hock B; Schwarz M; Domke I; Grunert VP; Wuertemberger M; Schiemann U; Horster S; Limmer C; Stecker G; Soyka M
    Addiction; 2005 Oct; 100(10):1477-86. PubMed ID: 16185209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum soluble urokinase plasminogen activator receptor in alcoholics: relation to liver disease severity, fibrogenesis, and alcohol use.
    Tuomi H; Kultti J; Danielsson J; Kangastupa P; Akerman K; Niemelä O
    J Gastroenterol Hepatol; 2014 Dec; 29(12):1991-5. PubMed ID: 24909734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of fibrosis markers for staging liver fibrosis in patients with precirrhotic alcoholic liver disease.
    Lieber CS; Weiss DG; Paronetto F;
    Alcohol Clin Exp Res; 2008 Jun; 32(6):1031-9. PubMed ID: 18422837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbohydrate-deficient transferrin as compared to other markers of alcoholism: a systematic review.
    Salaspuro M
    Alcohol; 1999 Nov; 19(3):261-71. PubMed ID: 10580517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.